Renal denervation in hypertension: debating the benefits and limitations
10.12025/j.issn.1008-6358.2025.20250229
- VernacularTitle:去肾神经术在高血压治疗优、劣的争与辩
- Author:
Ningling SUN
1
Author Information
1. Department of Cardiovascular Medicine, Peking University People’s Hospital, Beijing 100044, China.
- Publication Type:Monographicreport:Applicationofrenaldenervationinthetreatmentofhypertension
- Keywords:
renal denervation;
hypertension;
interventional therapy
- From:
Chinese Journal of Clinical Medicine
2025;32(6):917-924
- CountryChina
- Language:Chinese
-
Abstract:
After more than 10 years of development, renal denervation (RDN) has become an interventional method for the treatment of hypertension. As the “third pillar” of hypertension management, the research and development process has been bumpy and long, with controversies, challenges and consensus. In terms of different views on basic theory, technology and efficacy evaluation, it is suggested to take science and data as the criterion in disputes, keep a clear mind, and obtain consensus from practice.
